MedTrace Logo

Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers

NCT05028764 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-02-24

No results posted yet for this study

Summary

To examine range of tissue frataxin (FXN) concentrations, specific ribonucleic acids, other proteins and specialized lipids in the buccal cells, blood, and skin cells of normal healthy volunteers without Friedreich's ataxia (FRDA).

Conditions

  • Friedreich Ataxia
  • Healthy Volunteers

Interventions

DIAGNOSTIC_TEST

Buccal Swabs, Blood Draws and Skin Punch Biopsy

Buccal Swabs - FXN and specific RNA markers; Blood Draws - Lipid panel, Protein Marker Analysis and Gene RNA Analysis; Skin Punch Biopsy - Protein Markers

Sponsors & Collaborators

  • Clinilabs, Inc.

    collaborator OTHER

  • Larimar Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Magdy Shenouda, M.D. · Clinilabs, Inc.

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-04
Primary Completion
2022-02-04
Completion
2022-02-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05028764 on ClinicalTrials.gov